Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26Q3, 26 TTM Selling/general/admin expenses 515 M500 M538 M568 M506 M527 M559 M 2.16 B Research & development ——————— — Operating income 580 M100 M260 M158 M302 M435 M362 M 1.26 B Non-Operating Income, Total -102 M-70 M-67 M-90 M-175 M-76 M-96 M -437 M Interest expense, net of interest capitalized 120 M110 M113 M106 M104 M97 M98 M 405 M Non-Operating Income, excl. Interest Expenses -95 M-93 M-98 M-90 M-91 M-89 M-92 M -362 M Unusual income/expense -7 M23 M31 M0-84 M13 M-4 M -75 M Pretax income 478 M30 M193 M68 M127 M359 M266 M 820 M Equity in earnings ——————— — Taxes 112 M16 M124 M10 M37 M95 M80 M 222 M Non-controlling/minority interest 7 M7 M8 M11 M5 M4 M4 M 24 M After tax other income/expense -78 M-68 M-12 M151 M-163 M-30 M-37 M -79 M Net income before discontinued operations 359 M7 M61 M47 M85 M260 M182 M 574 M Discontinued operations ——————— — Net income 359 M7 M61 M47 M85 M260 M182 M 574 M Dilution adjustment ——————— — Preferred dividends ——————— — Diluted net income available to common stockholders 359 M7 M61 M47 M85 M260 M182 M 574 M Basic earnings per share (Basic EPS) 1.960.030.340.260.471.431.01 3.17 Diluted earnings per share (Diluted EPS) 1.010.020.170.130.240.730.52 1.62 Average basic shares outstanding 355 M355 M355 M355 M352 M353 M352 M — Diluted shares outstanding 357 M357 M357 M357 M354 M354 M355 M — EBITDA 928 M452 M589 M-103 M678 M785 M691 M 2.05 B EBIT 580 M100 M260 M-424 M302 M435 M362 M 675 M Cost of revenue 12.53 B12.47 B12.74 B13.13 B13.51 B12.69 B12.95 B 52.28 B Other cost of goods sold ——————— — Depreciation & amortization (cash flow) 348 M352 M329 M321 M376 M350 M329 M 1.38 B